In some previous randomized trials, vitamin D3 supplementation reduced high-sensitivity C-reactive protein (hs-CRP) in patients with diabetes [14], psychiatric disorders [15], and polycystic ovary syndrome [16], and reduced tumor necrosis factor-α (TNF-α) in patients with diabetes [17]. Here, TNF is linked to psychiatric disorder.